Publication | Open Access
Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma
84
Citations
30
References
2013
Year
Pentraxin family members, especially PTX3, may be used as promising biomarkers in the prognosis of pancreatic carcinoma patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1